Teva Pushes For Progress On Asthma Rescue Inhaler
Firm Agrees Clinical Collaboration And Funding Deals For Respiratory Asset
Teva has struck a $150m strategic development funding agreement with Abingworth and a clinical collaboration agreement with Launch Therapeutics to accelerate development of a dual-action asthma rescue inhaler.
